Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. [electronic resource]
Producer: 20080811Description: 664-76 p. digitalISSN:- 1748-7838
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- drug therapy
- CASP8 and FADD-Like Apoptosis Regulating Protein -- genetics
- Caspases -- metabolism
- Cell Line, Tumor
- Cell Membrane -- drug effects
- Death Domain Receptor Signaling Adaptor Proteins -- metabolism
- Down-Regulation -- drug effects
- Drug Screening Assays, Antitumor
- E2F1 Transcription Factor -- metabolism
- Enzyme Activation -- drug effects
- Fas-Associated Death Domain Protein -- metabolism
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Membrane Microdomains -- drug effects
- Myeloid Cell Leukemia Sequence 1 Protein
- Protein Isoforms -- genetics
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Purines -- pharmacology
- RNA, Messenger -- genetics
- RNA, Small Interfering -- metabolism
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- metabolism
- Roscovitine
- TNF-Related Apoptosis-Inducing Ligand -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.